| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |